Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 160

1.

Genotypes of Staphylococcus aureus: On-farm epidemiology and the consequences for prevention of intramammary infections.

Leuenberger A, Sartori C, Boss R, Resch G, Oechslin F, Steiner A, Moreillon P, Graber HU.

J Dairy Sci. 2019 Apr;102(4):3295-3309. doi: 10.3168/jds.2018-15181. Epub 2019 Feb 7.

2.

Marginal role of von Willebrand factor-binding protein and coagulase in the initiation of endocarditis in rats with catheter-induced aortic vegetations.

Mancini S, Oechslin F, Menzi C, Que YA, Claes J, Heying R, Veloso TR, Vanassche T, Missiakas D, Schneewind O, Moreillon P, Entenza JM.

Virulence. 2018;9(1):1615-1624. doi: 10.1080/21505594.2018.1528845.

3.

Assessment of the Dual Role of Clumping Factor A in S. Aureus Adhesion to Endothelium in Absence and Presence of Plasma.

Claes J, Ditkowski B, Liesenborghs L, Veloso TR, Entenza JM, Moreillon P, Vanassche T, Verhamme P, Hoylaerts MF, Heying R.

Thromb Haemost. 2018 Jul;118(7):1230-1241. doi: 10.1055/s-0038-1660435. Epub 2018 Jun 17.

PMID:
29909601
4.

In vitro characterization of PlyE146, a novel phage lysin that targets Gram-negative bacteria.

Larpin Y, Oechslin F, Moreillon P, Resch G, Entenza JM, Mancini S.

PLoS One. 2018 Feb 6;13(2):e0192507. doi: 10.1371/journal.pone.0192507. eCollection 2018.

5.

Synergistic Interaction Between Phage Therapy and Antibiotics Clears Pseudomonas Aeruginosa Infection in Endocarditis and Reduces Virulence.

Oechslin F, Piccardi P, Mancini S, Gabard J, Moreillon P, Entenza JM, Resch G, Que YA.

J Infect Dis. 2017 Mar 1;215(5):703-712. doi: 10.1093/infdis/jiw632.

6.

Muropeptide signature of inhibitors of protein synthesis correlates with β-lactam synergism against methicillin-resistant Staphylococcus aureus.

Guignard B, Majcherczyk PA, Monachon C, Vouillamoz J, Moreillon P.

Int J Antimicrob Agents. 2017 Jan;49(1):53-61. doi: 10.1016/j.ijantimicag.2016.09.028. Epub 2016 Nov 16.

PMID:
27887965
7.

Antibodies Targeting Hsa and PadA Prevent Platelet Aggregation and Protect Rats against Experimental Endocarditis Induced by Streptococcus gordonii.

Mancini S, Menzi C, Oechslin F, Moreillon P, Entenza JM.

Infect Immun. 2016 Nov 18;84(12):3557-3563. Print 2016 Dec.

8.

In Vitro and In Vivo Effectiveness of an Innovative Silver-Copper Nanoparticle Coating of Catheters To Prevent Methicillin-Resistant Staphylococcus aureus Infection.

Ballo MK, Rtimi S, Pulgarin C, Hopf N, Berthet A, Kiwi J, Moreillon P, Entenza JM, Bizzini A.

Antimicrob Agents Chemother. 2016 Aug 22;60(9):5349-56. doi: 10.1128/AAC.00959-16. Print 2016 Sep.

9.

Development of Potent and Selective S. aureus Sortase A Inhibitors Based on Peptide Macrocycles.

Rentero Rebollo I, McCallin S, Bertoldo D, Entenza JM, Moreillon P, Heinis C.

ACS Med Chem Lett. 2016 Apr 14;7(6):606-11. doi: 10.1021/acsmedchemlett.6b00045. eCollection 2016 Jun 9.

10.

Excision of staphylococcal cassette chromosome mec in methicillin-resistant Staphylococcus aureus assessed by quantitative PCR.

Stojanov M, Moreillon P, Sakwinska O.

BMC Res Notes. 2015 Dec 29;8:828. doi: 10.1186/s13104-015-1815-3.

11.

Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus.

del Río A, García-de-la-Mària C, Entenza JM, Gasch O, Armero Y, Soy D, Mestres CA, Pericás JM, Falces C, Ninot S, Almela M, Cervera C, Gatell JM, Moreno A, Moreillon P, Marco F, Miró JM; Hospital Clinic Experimental Endocarditis Study Group.

Antimicrob Agents Chemother. 2015 Nov 2;60(1):478-86. doi: 10.1128/AAC.02139-15. Print 2016 Jan.

12.

Aspirin plus ticlopidine prevented experimental endocarditis due to Enterococcus faecalis and Streptococcus gallolyticus.

Veloso TR, Oechslin F, Que YA, Moreillon P, Entenza JM, Mancini S.

Pathog Dis. 2015 Nov;73(8):ftv060. doi: 10.1093/femspd/ftv060. Epub 2015 Aug 26.

13.

Vaccination against Staphylococcus aureus experimental endocarditis using recombinant Lactococcus lactis expressing ClfA or FnbpA.

Veloso TR, Mancini S, Giddey M, Vouillamoz J, Que YA, Moreillon P, Entenza JM.

Vaccine. 2015 Jul 9;33(30):3512-7. doi: 10.1016/j.vaccine.2015.05.060. Epub 2015 Jun 3.

PMID:
26048778
14.

Reply to Eisen and McBryde.

Veloso TR, Que YA, Moreillon P, Entenza JM.

J Infect Dis. 2015 Aug 15;212(4):674-5. doi: 10.1093/infdis/jiv133. Epub 2015 Mar 9. No abstract available.

PMID:
25754979
15.

In vivo effect of flucloxacillin in experimental endocarditis caused by mecC-positive staphylococcus aureus showing temperature-dependent susceptibility in vitro.

Mancini S, Laurent F, Veloso TR, Giddey M, Vouillamoz J, Vandenesch F, Moreillon P, Entenza JM.

Antimicrob Agents Chemother. 2015 Apr;59(4):2435-8. doi: 10.1128/AAC.04733-14. Epub 2015 Jan 20.

16.

Assessment of the in vitro synergy of daptomycin plus linezolid against multidrug-resistant enterococci.

Entenza JM, Giddey M, Vouillamoz J, Moreillon P, Mancini S.

J Glob Antimicrob Resist. 2014 Dec;2(4):306-308. doi: 10.1016/j.jgar.2014.09.004. Epub 2014 Oct 2.

PMID:
27873692
17.

Prophylaxis of experimental endocarditis with antiplatelet and antithrombin agents: a role for long-term prevention of infective endocarditis in humans?

Veloso TR, Que YA, Chaouch A, Giddey M, Vouillamoz J, Rousson V, Moreillon P, Entenza JM.

J Infect Dis. 2015 Jan 1;211(1):72-9. doi: 10.1093/infdis/jiu426. Epub 2014 Aug 1.

PMID:
25086177
18.

In vitro characterization of PlySK1249, a novel phage lysin, and assessment of its antibacterial activity in a mouse model of Streptococcus agalactiae bacteremia.

Oechslin F, Daraspe J, Giddey M, Moreillon P, Resch G.

Antimicrob Agents Chemother. 2013 Dec;57(12):6276-83. doi: 10.1128/AAC.01701-13. Epub 2013 Oct 7.

19.

Bactericidal synergism between daptomycin and the phage lysin Cpl-1 in a mouse model of pneumococcal bacteraemia.

Vouillamoz J, Entenza JM, Giddey M, Fischetti VA, Moreillon P, Resch G.

Int J Antimicrob Agents. 2013 Nov;42(5):416-21. doi: 10.1016/j.ijantimicag.2013.06.020. Epub 2013 Aug 9.

PMID:
23992647
20.

Streptococcus tigurinus is highly virulent in a rat model of experimental endocarditis.

Veloso TR, Zbinden A, Andreoni F, Giddey M, Vouillamoz J, Moreillon P, Zinkernagel AS, Entenza JM.

Int J Med Microbiol. 2013 Dec;303(8):498-504. doi: 10.1016/j.ijmm.2013.06.006. Epub 2013 Jun 20.

PMID:
23856340
21.

Human-to-bovine jump of Staphylococcus aureus CC8 is associated with the loss of a β-hemolysin converting prophage and the acquisition of a new staphylococcal cassette chromosome.

Resch G, François P, Morisset D, Stojanov M, Bonetti EJ, Schrenzel J, Sakwinska O, Moreillon P.

PLoS One. 2013;8(3):e58187. doi: 10.1371/journal.pone.0058187. Epub 2013 Mar 11.

22.

A positive interaction between inhibitors of protein synthesis and cefepime in the fight against methicillin-resistant Staphylococcus aureus.

Guignard B, Vouillamoz J, Giddey M, Moreillon P.

Eur J Clin Microbiol Infect Dis. 2013 Jul;32(7):899-907. doi: 10.1007/s10096-013-1824-x. Epub 2013 Jan 31.

PMID:
23370969
23.

Use of a human-like low-grade bacteremia model of experimental endocarditis to study the role of Staphylococcus aureus adhesins and platelet aggregation in early endocarditis.

Veloso TR, Chaouch A, Roger T, Giddey M, Vouillamoz J, Majcherczyk P, Que YA, Rousson V, Moreillon P, Entenza JM.

Infect Immun. 2013 Mar;81(3):697-703. doi: 10.1128/IAI.01030-12. Epub 2012 Dec 17.

24.

Expression of SCCmec cassette chromosome recombinases in methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.

Stojanov M, Sakwinska O, Moreillon P.

J Antimicrob Chemother. 2013 Apr;68(4):749-57. doi: 10.1093/jac/dks494. Epub 2012 Dec 18.

PMID:
23249841
25.

Antimicrobial resistance of Staphylococcus aureus strains acquired by pig farmers from pigs.

Oppliger A, Moreillon P, Charrière N, Giddey M, Morisset D, Sakwinska O.

Appl Environ Microbiol. 2012 Nov;78(22):8010-4. doi: 10.1128/AEM.01902-12. Epub 2012 Sep 7.

26.

Proteomic and transcriptomic profiling of Staphylococcus aureus surface LPXTG-proteins: correlation with agr genotypes and adherence phenotypes.

Ythier M, Resch G, Waridel P, Panchaud A, Gfeller A, Majcherczyk P, Quadroni M, Moreillon P.

Mol Cell Proteomics. 2012 Nov;11(11):1123-39. doi: 10.1074/mcp.M111.014191. Epub 2012 Jul 25.

27.

Daptomycin for highly resistant Enterococcus faecium infection.

Rosin C, Bernsmeier C, Entenza JM, Moreillon P, Frei R, Weisser M, Flückiger U.

Swiss Med Wkly. 2012 Jun 26;142:w13603. doi: 10.4414/smw.2012.13603. eCollection 2012.

28.

High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis.

Miró JM, Entenza JM, Del Río A, Velasco M, Castañeda X, Garcia de la Mària C, Giddey M, Armero Y, Pericàs JM, Cervera C, Mestres CA, Almela M, Falces C, Marco F, Moreillon P, Moreno A; Hospital Clinic Experimental Endocarditis Study Group.

Antimicrob Agents Chemother. 2012 Aug;56(8):4511-5. Epub 2012 May 29.

29.

Deletion of hypothetical wall teichoic acid ligases in Staphylococcus aureus activates the cell wall stress response.

Dengler V, Meier PS, Heusser R, Kupferschmied P, Fazekas J, Friebe S, Staufer SB, Majcherczyk PA, Moreillon P, Berger-Bächi B, McCallum N.

FEMS Microbiol Lett. 2012 Aug;333(2):109-20. doi: 10.1111/j.1574-6968.2012.02603.x. Epub 2012 Jun 18.

30.

Evidence for a new post-translational modification in Staphylococcus aureus: hydroxymethylation of asparagine and glutamine.

Waridel P, Ythier M, Gfeller A, Moreillon P, Quadroni M.

J Proteomics. 2012 Mar 16;75(6):1742-51. doi: 10.1016/j.jprot.2011.12.014. Epub 2011 Dec 20.

PMID:
22207155
31.

Vancomycin-intermediate Staphylococcus aureus selected during vancomycin therapy of experimental endocarditis are not detected by culture-based diagnostic procedures and persist after treatment arrest.

Moreillon P, Bizzini A, Giddey M, Vouillamoz J, Entenza JM.

J Antimicrob Chemother. 2012 Mar;67(3):652-60. doi: 10.1093/jac/dkr521. Epub 2011 Dec 13.

PMID:
22167243
32.

Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure.

Kiefer T, Park L, Tribouilloy C, Cortes C, Casillo R, Chu V, Delahaye F, Durante-Mangoni E, Edathodu J, Falces C, Logar M, Miró JM, Naber C, Tripodi MF, Murdoch DR, Moreillon P, Utili R, Wang A.

JAMA. 2011 Nov 23;306(20):2239-47. doi: 10.1001/jama.2011.1701.

33.

Molecular characterization of a Streptococcus gallolyticus genomic island encoding a pilus involved in endocarditis.

Danne C, Entenza JM, Mallet A, Briandet R, Débarbouillé M, Nato F, Glaser P, Jouvion G, Moreillon P, Trieu-Cuot P, Dramsi S.

J Infect Dis. 2011 Dec 15;204(12):1960-70. doi: 10.1093/infdis/jir666. Epub 2011 Oct 31.

PMID:
22043018
34.

PEGylating a bacteriophage endolysin inhibits its bactericidal activity.

Resch G, Moreillon P, Fischetti VA.

AMB Express. 2011 Oct 7;1:29. doi: 10.1186/2191-0855-1-29.

35.

A stable phage lysin (Cpl-1) dimer with increased antipneumococcal activity and decreased plasma clearance.

Resch G, Moreillon P, Fischetti VA.

Int J Antimicrob Agents. 2011 Dec;38(6):516-21. doi: 10.1016/j.ijantimicag.2011.08.009. Epub 2011 Oct 5.

PMID:
21982146
36.

Continuous infusion may improve the efficacy of vancomycin in treatment of experimental endocarditis due to heterogeneous vancomycin-intermediate Staphylococcus aureus.

Pea F, Cojutti P, Petrosillo N, Furlanut M, Entenza JM, Veloso TR, Vouillamoz J, Giddey M, Moreillon P.

Antimicrob Agents Chemother. 2011 Sep;55(9):4496; author reply 4496-7. doi: 10.1128/AAC.00603-11. No abstract available.

37.

Staphylococcus aureus host range and human-bovine host shift.

Sakwinska O, Giddey M, Moreillon M, Morisset D, Waldvogel A, Moreillon P.

Appl Environ Microbiol. 2011 Sep;77(17):5908-15. doi: 10.1128/AEM.00238-11. Epub 2011 Jul 8.

38.

In vivo synergism of ceftobiprole and vancomycin against experimental endocarditis due to vancomycin-intermediate Staphylococcus aureus.

Entenza JM, Veloso TR, Vouillamoz J, Giddey M, Majcherczyk P, Moreillon P.

Antimicrob Agents Chemother. 2011 Sep;55(9):3977-84. doi: 10.1128/AAC.00402-11. Epub 2011 Jul 5.

39.

Infective endocarditis.

Que YA, Moreillon P.

Nat Rev Cardiol. 2011 Jun;8(6):322-36. doi: 10.1038/nrcardio.2011.43. Epub 2011 Apr 12. Review.

PMID:
21487430
40.

Link between genotype and antimicrobial resistance in bovine mastitis-related Staphylococcus aureus strains, determined by comparing Swiss and French isolates from the Rhône Valley.

Sakwinska O, Morisset D, Madec JY, Waldvogel A, Moreillon P, Haenni M.

Appl Environ Microbiol. 2011 May;77(10):3428-32. doi: 10.1128/AEM.02468-10. Epub 2011 Mar 18.

41.

Induction of experimental endocarditis by continuous low-grade bacteremia mimicking spontaneous bacteremia in humans.

Veloso TR, Amiguet M, Rousson V, Giddey M, Vouillamoz J, Moreillon P, Entenza JM.

Infect Immun. 2011 May;79(5):2006-11. doi: 10.1128/IAI.01208-10. Epub 2011 Feb 14.

42.

Failure of vancomycin continuous infusion against experimental endocarditis due to vancomycin-intermediate Staphylococcus aureus.

Entenza JM, Veloso TR, Vouillamoz J, Giddey M, Moreillon P.

Antimicrob Agents Chemother. 2011 Jan;55(1):385-7. doi: 10.1128/AAC.00811-10. Epub 2010 Oct 18.

43.

Ecological temporal stability of Staphylococcus aureus nasal carriage.

Sakwinska O, Blanc DS, Lazor-Blanchet C, Moreillon M, Giddey M, Moreillon P.

J Clin Microbiol. 2010 Aug;48(8):2724-8. doi: 10.1128/JCM.02091-09. Epub 2010 Jun 2.

44.

Prospective monitoring of cefepime in intensive care unit adult patients.

Chapuis TM, Giannoni E, Majcherczyk PA, Chioléro R, Schaller MD, Berger MM, Bolay S, Décosterd LA, Bugnon D, Moreillon P.

Crit Care. 2010;14(2):R51. doi: 10.1186/cc8941. Epub 2010 Apr 1.

45.

Bonds between fibronectin and fibronectin-binding proteins on Staphylococcus aureus and Lactococcus lactis.

Buck AW, Fowler VG Jr, Yongsunthon R, Liu J, DiBartola AC, Que YA, Moreillon P, Lower SK.

Langmuir. 2010 Jul 6;26(13):10764-70. doi: 10.1021/la100549u.

46.

In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin.

Entenza JM, Giddey M, Vouillamoz J, Moreillon P.

Int J Antimicrob Agents. 2010 May;35(5):451-6. doi: 10.1016/j.ijantimicag.2009.12.022. Epub 2010 Feb 24.

PMID:
20185277
47.

Penicillin-binding protein gene alterations in Streptococcus uberis isolates presenting decreased susceptibility to penicillin.

Haenni M, Galofaro L, Ythier M, Giddey M, Majcherczyk P, Moreillon P, Madec JY.

Antimicrob Agents Chemother. 2010 Mar;54(3):1140-5. doi: 10.1128/AAC.00915-09. Epub 2010 Jan 11.

48.

Natural variability of in vitro adherence to fibrinogen and fibronectin does not correlate with in vivo infectivity of Staphylococcus aureus.

Ythier M, Entenza JM, Bille J, Vandenesch F, Bes M, Moreillon P, Sakwinska O.

Infect Immun. 2010 Apr;78(4):1711-6. doi: 10.1128/IAI.01274-09. Epub 2010 Jan 11.

49.

A single mutation in enzyme I of the sugar phosphotransferase system confers penicillin tolerance to Streptococcus gordonii.

Bizzini A, Entenza JM, Michielin O, Arnold I, Erni B, Moreillon P.

Antimicrob Agents Chemother. 2010 Jan;54(1):259-66. doi: 10.1128/AAC.00699-09. Epub 2009 Oct 26.

50.

Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer.

Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, Moreillon P, de Jesus Antunes M, Thilen U, Lekakis J, Lengyel M, Müller L, Naber CK, Nihoyannopoulos P, Moritz A, Zamorano JL; ESC Committee for Practice Guidelines.

Eur Heart J. 2009 Oct;30(19):2369-413. doi: 10.1093/eurheartj/ehp285. Epub 2009 Aug 27. No abstract available.

PMID:
19713420

Supplemental Content

Loading ...
Support Center